Risk factors

Enveric Biosciences faces going concern and liquidity pressures while advancing its lead candidate EB-003 through preclinical stages.

Epsilon Energy expanded operations into Wyoming, creating customer concentration risks with HF Sinclair and WGR Operating.

EQV Ventures Acquisition Corp. II holds approximately $469.0 million in its trust account as of December 31, 2025.

International expansion now emphasizes dependence on Norgine, other partners, foreign approvals, and Middle East distribution disruptions.

The company shifted its entire business strategy to focus on holding ETH and participating in staking activities. It dropped all legacy risks related to merchant banking, mergers, and cinema equipment distribution. The new risk profile focuses heavily on crypto regulation, network security, and smart contract vulnerabilities.

Fusemachines faces heavy reliance on its international operations in Nepal, subject to political volatility and economic disruption. The company reports historical losses, material weaknesses in internal controls, and needs additional capital to fund operations. Sales cycles for enterprise AI products are long and unpredictable, with growing risks from AI algorithms and data security.

GDC added risks regarding Bitcoin volatility, going concern doubts, and Nasdaq listing compliance.

General Purpose Acquisition Corp. operates as a blank check company formed to complete an initial business combination. The company completed an initial public offering raising significant capital held in a trust account. Operations are focused on sourcing and consummating a qualifying business combination.

GSR IV Acquisition Corp. is a blank check company holding $232,887,973 in a trust account following its September 2025 IPO. The company faces mandatory liquidation if it fails to complete an initial business combination.

Activist shareholder costs and settlement details with Star Equity were added as significant new risk factors.

Werewolf Therapeutics faces a going concern warning with $57.1 million in cash and substantial operating losses.

Highview Merger Corp is a blank check company seeking an initial business combination with a target enterprise value of $750 million to $1.5 billion or more. Operations are exposed to risks surrounding redemption rights, trust account security, management conflicts of interest, and target acquisition complexities.